Atara Biotherapeutics Inc., which is developing therapies for illnesses such as kidney disease and ovarian cancer, has filed for an initial public offering, according to a September 26 filing with the Security and Exchange Commission. Mexican telecom billionaire Carlos Slim’s family trust owns 9.3%. Other shareholders include Silicon Valley venture capital firm Kleiner Perkins, with an 18% stake, and biotech firms Celgene and Amgen, which own 8.7% and 8.6%, respectively.
Hey, check out all the research scientist jobs. Post your resume today!
